1. Control of Hedgehog Signalling by the Cilia-Regulated Proteasome
    Christoph Gerhardt et al, 2016, JDB CrossRef
  2. Positioning of proteasome inhibitors in therapy of solid malignancies
    Margot S. F. Roeten et al, 2017, Cancer Chemother Pharmacol CrossRef
  3. Research progress on therapeutic targeting of quiescent cancer cells
    Jinhua Zhang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  4. The cilia-regulated proteasome and its role in the development of ciliopathies and cancer
    Christoph Gerhardt et al, 2016, Cilia CrossRef
  5. The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
    G.R. Tundo et al, 2020, Pharmacology & Therapeutics CrossRef
  6. Fe3O4 magnetic nanoparticle-enhanced radiotherapy for lung adenocarcinoma via delivery of siBIRC5 and AS-ODN
    Shuzhen Chen et al, 2021, J Transl Med CrossRef
  7. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
    Zheng Zheng et al, 2023, Exp Ther Med CrossRef
  8. First-principles study of V3+ adsorption on MXene toward vanadium redox flow battery
    Qiang Li et al, 2023, Computational and Theoretical Chemistry CrossRef
  9. The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity
    Mengyun Zhang et al, 2023, Biomedicines CrossRef